Paper39807474
Effects of therapy in experimental models of Peyronie's disease: a scoping review.
Wiborg MH and 3 others. Sex Med, 2024. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. Effects of therapy in experimental models of Peyronie's disease: a scoping review. Papers, record 39807474. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39807474
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References70
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 25156514 | The anti-inflammatory and antifibrosis effects of anthocyanin extracted from black soybean on a Peyronie disease rat model. | Urology | 2014 | https://conductscience.org/library/papers/25156514 | PubMed |
| 2 | 34559023 | Laboratory animals search filter for different literature databases: PubMed, Embase, Web of Science and PsycINFO. | Lab Anim | 2022 | https://conductscience.org/library/papers/34559023 | PubMed |
| 3 | 16469038 | Effects of long-term vardenafil treatment on the development of fibrotic plaques in a rat model of Peyronie's disease. | BJU Int | 2006 | https://conductscience.org/library/papers/16469038 | PubMed |
| 4 | 35908015 | Intratunical injection of rat-derived bone marrow mesenchymal stem cells prevents fibrosis and is associated with increased Smad7 expression in a rat model of Peyronie's disease. | Stem Cell Res Ther | 2022 | https://conductscience.org/library/papers/35908015 | PubMed |
| 5 | 25847891 | Smoking, diabetes, blood hypertension: possible etiologic role for Peyronie's disease? Analysis in 279 patients with a control group in Sicily. | Arch Ital Urol Androl | 2015 | https://conductscience.org/library/papers/25847891 | PubMed |
| 6 | 1486392 | The treatment of Peyronie's disease with tamoxifen. | Br J Urol | 1992 | https://conductscience.org/library/papers/1486392 | PubMed |
| 7 | 37926870 | The Effect of Pirfenidone on Peyronie Plaques and Erectile Function in a Peyronie's Rat Model. | J Coll Physicians Surg Pak | 2023 | https://conductscience.org/library/papers/37926870 | PubMed |
| 8 | 30387224 | Prevalence of penile curvature: a population-based cross-sectional study in metropolitan and rural cities in Australia. | BJU Int | 2018 | https://conductscience.org/library/papers/30387224 | PubMed |
| 9 | 33038124 | Updated methodological guidance for the conduct of scoping reviews. | JBI Evid Synth | 2020 | https://conductscience.org/library/papers/33038124 | PubMed |
| 10 | 9302128 | Peyronie's disease is associated with an increase in transforming growth factor-beta protein expression. | J Urol | 1997 | https://conductscience.org/library/papers/9302128 | PubMed |
| 11 | 12454687 | Gene expression in Peyronie's disease. | Int J Impot Res | 2002 | https://conductscience.org/library/papers/12454687 | PubMed |
| 12 | 21633367 | The association between Peyronie's and Dupuytren's disease. | Int J Impot Res | 2011 | https://conductscience.org/library/papers/21633367 | PubMed |
| 13 | 37547872 | European Society of Sexual Medicine consensus statement on the use of animal models for studying Peyronie's disease. | Sex Med | 2023 | https://conductscience.org/library/papers/37547872 | PubMed |
| 14 | 38672406 | Uncovering Novel Protein Partners of Inducible Nitric Oxide Synthase in Human Testis. | Biomolecules | 2024 | https://conductscience.org/library/papers/38672406 | PubMed |
| 15 | 30670839 | Therapeutic areas of Li-ESWT in sexual medicine other than erectile dysfunction. | Int J Impot Res | 2019 | https://conductscience.org/library/papers/30670839 | PubMed |
| 16 | 37373277 | Molecular Mechanisms and Risk Factors Related to the Pathogenesis of Peyronie's Disease. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37373277 | PubMed |
| 17 | 19267860 | Mechanisms of penile fibrosis. | J Sex Med | 2009 | https://conductscience.org/library/papers/19267860 | PubMed |
| 18 | 31000815 | Anti-fibrotic effect of mycophenolate mofetil on Peyronie's disease experimentally induced with TGF-β. | Int J Impot Res | 2020 | https://conductscience.org/library/papers/31000815 | PubMed |
| 19 | 10332485 | The effects of colchicine on a Peyronie's-like condition in an animal model. | J Urol | 1999 | https://conductscience.org/library/papers/10332485 | PubMed |
| 20 | 10799245 | A rat model of Peyronie's disease associated with a decrease in erectile activity and an increase in inducible nitric oxide synthase protein expression. | J Urol | 2000 | https://conductscience.org/library/papers/10799245 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 39807474 | Effects of therapy in experimental models of Peyronie's disease: a scoping review. | Sex Med | 2024 | https://conductscience.org/library/papers/39807474 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39807474
GET https://conductscience.org/api/papers/v1/39807474/references?page=2